Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Research graph
References from MATLAB®-based fitting method to evaluate survival fractions after multimodal treatment. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
2006 · External reference
The radioresponsiveness of human tumours and the initial slope of the cell survival curve
10.1016/s0167-8140(84)80074-2 · 1984 · External reference
Distribution of radiation sensitivities for human tumor cells of specific histological types: comparison of in vitro to in vivo data
10.1016/0360-3016(86)90071-4 · 1986 · External reference
Radiosensitization in esophageal squamous cell carcinoma: effect of polo-like kinase 1 inhibition
10.1007/s00066-016-0951-6 · 2016 · External reference
10.1007/s00066-017-1223-9
10.1007/s00066-017-1223-9 · External reference
10.1016/j.ctro.2017.09.006 · 2017 · Admitted local publication
Clonogenic assay of cells in vitro
10.1038/nprot.2006.339 · 2006 · External reference
Unresolved reference
External reference
Parameters of linear-quadratic radiation dose-effect relationships: dependence on LET and mechanisms of reproductive cell death
10.1080/095530097143653 · 1997 · External reference
The first James Kirk memorial lecture. What next in fractionated radiotherapy?
1984 · External reference
The biophysical properties of 3.9-GeV nitrogen ions. VI. Interpretation of results
10.2307/3573850 · 1973 · External reference
Aurora kinase inhibitor ZM447439 induces apoptosis via mitochondrial pathways
10.1016/j.bcp.2009.08.011 · 2010 · External reference
Unresolved reference
External reference
Unresolved reference
2013 · External reference
Unresolved reference
External reference
10.1007/3-540-31303-6
10.1007/3-540-31303-6 · External reference
Final results of the randomized phase III CHARTWEL-trial (ARO 97–1) comparing hyperfractionated-accelerated versus conventionally fractionated radiotherapy in non-small cell lung cancer (NSCLC)
10.1016/j.radonc.2011.06.031 · 2011 · External reference
From CHART to CHARTWEL in non-small cell lung cancer: clinical radiobiological modelling of the expected change in outcome
10.1053/clon.2002.0117 · 2002 · External reference
The linear-quadratic formula and progress in fractionated radiotherapy
10.1259/0007-1285-62-740-679 · 1989 · External reference
Time-dose factors in radiotherapy: a review of the human data
10.1016/0167-8140(90)90149-q · 1990 · External reference
The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction
10.1016/j.semradonc.2008.04.004 · 2008 · External reference
The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved?
10.1016/j.ijrobp.2013.07.022 · 2014 · External reference
The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery
10.1016/j.semradonc.2008.04.005 · 2008 · External reference
Use of the LQ model with large fraction sizes results in underestimation of isoeffect doses
10.1016/j.radonc.2013.08.027 · 2013 · External reference
Cell survival and radiosensitisation: modulation of the linear and quadratic parameters of the LQ model (Review)
10.3892/ijo.2013.1857 · 2013 · External reference